Inclusion Criteria:  Documented informed consent of the participant >= 65 years at time of planned HCT infusion Anticipated to be candidate for allogeneic transplant per treating physician at the time of enrollment Ability to read English, Spanish or Mandarin. Other languages will be acceptable with principal investigator (PI) agreement if surveys are available and language does not preclude completing study procedures Any conditioning regimen and allogeneic donor permitted Hematologic malignancy or disease as indication for HCT Willing and able to complete study requirements  Exclusion Criteria:  Prior allogeneic stem cell transplant Syngeneic donors for HCT Any other condition that would, in the Investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures